SCHEMBL23809272

SCHEMBL23809272

COCCOCCn1c(C(=O)O)cc2cc(C)cc(C(C)C)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GPR35 Q9HC97 3/20 0.32
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
HASPIN Q8TF76 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
NPC1 O15118 1/20 0.31
PKM P14618 1/20 0.31
NFKB1 P19838 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
XDH P47989 1/20 0.31
PTGER4 P35408 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809284 0.93 ALDH1A1 (0.38) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23809535 0.88 KDM4E (0.36) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL26036900 0.88 MCL1 (0.39) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL26042239 0.88 ALDH1A1 (0.32) ALDH1A1
SCHEMBL26581649 0.85 MCL1 (0.38) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23809274 0.85 CCR2 (0.40) MCL1ALDH1A1KDM4ESMN1; SMN2NPC1
SCHEMBL23809536 0.84 ALDH1A1 (0.33) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23809113 0.82 FABP3 (0.41) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23809370 0.81 DHODH (0.39) MCL1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23809215 0.81 ALDH1A1 (0.41) MCL1ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MCL1 1/4885ALDH1A1 2556/4885KDM4E 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.